DBV Technologies S.A. (DBV.PA) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close1.7440

Open1.7270

Day range1.67401.7290

52-week range1.53404.5000

Off day high−1.33%

Off 52-week high−62.09%

Volume551.38K

Avg. volume (3M)1.09M

Market cap536.10M

EPS (TTM)-0.6000

Forward P/E-11.45

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)-0.24

Shares outstanding314.24M

Short interest—

Earnings dateOct 28, 2026

Analyst target3.6367

Profit margin0.00%

Against its peers

Compare in full ›

	DBV.PA	ATTO	ACRS	ABCL	QTTB	LKFT
Market cap	536.10M	654.18M	570.40M	3.69B	262.86M	2.06B
P/E (TTM)	—	—	—	—	2.8	3.0
Forward P/E	-11.4	-6.0	-4.9	-14.9	-8.7	-26.4
Price/book	3.5	-0.4	4.3	3.9	2.0	11.3
Dividend yield	—	—	—	—	—	—
1-year change	−33.05%	−35.25%	+68.58%	+114.36%	+209.64%	−4.53%
Today	−2.18%	+1.06%	+1.71%	−7.03%	+1.85%	+2.78%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to DBV.PA's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
Attovia Therapeutics, Inc.ATTO · Biotechnology	654.18M	14.33	+1.06%
Aclaris Therapeutics, Inc.ACRS · Biotechnology	570.40M	3.8750	+1.71%
AbCellera Biologics Inc.ABCL · Biotechnology	3.69B	11.38	−7.03%
Q32 Bio Inc.QTTB · Biotechnology	262.86M	8.83	+1.85%
Lakefront Biotherapeutics NVLKFT · Biotechnology	2.06B	31.43	+2.78%
Cabaletta Bio, Inc.CABA · Biotechnology	254.22M	1.4994	−2.64%
Protagonist Therapeutics, Inc.PTGX · Biotechnology	9.03B	139.60	+1.10%
Celldex Therapeutics, Inc.CLDX · Biotechnology	2.26B	28.75	−2.11%

What visitors to DBV.PA's page also look at.

Company	Mkt cap	Price	Today
GENFITGNFT.PA	448.78M	8.97	−3.24%
INNATE PHARMAIPH.PA	147.44M	1.3200	−2.08%
CELLECTISALCLS.PA	94.69M	0.9400	−5.53%
NANOBIOTIXNANO.PA	1.29B	25.26	+4.99%
ADOCIAADOC.PA	48.54M	2.3900	+1.27%

From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 15 min.

Latest news

All DBV.PA news ›

Defense World·5d agoPositive

Reviewing DBV Technologies (NASDAQ:DBVT) and Arrowhead Pharmaceuticals (NASDAQ:ARWR)

Posted by Defense World Staff on Oct 17th, 2026 DBV Technologies (NASDAQ:DBVT – Get Free Report) and Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast…

Markets Daily·Oct 15

DBV Technologies S.A. (NASDAQ:DBVT) Stock Has Consensus Target Price of $48.50 According to Analysts

Posted by Danessa Lincoln on Oct 15th, 2026 Read Our Latest Report on DBVT DBV Technologies is a clinical-stage biopharmaceutical company focused on developing treatments for food allergies and other immune-mediated conditions. The…

Markets Daily·Oct 14

DBV Technologies (NASDAQ:DBVT) Sets New 52-Week Low – What’s Next?

Posted by Danessa Lincoln on Oct 14th, 2026 DBV Technologies S.A. (NASDAQ:DBVT – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Wednesday. The company traded as low as $8.90 and last traded at $9.03, with a…

From articles in the 4Search news index.

In the news

12mentions in 30 days

7with it in the headline

Positivesentiment

Most coverage from

defenseworld.net2
themarketsdaily.com2
bnldata.com.br1
igamingbusiness.com1
kalkinemedia.com1

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.